Efficacy and tolerability of perampanel as an adjunct therapy in refractory epilepsy from real-world experience

J Neurol Sci. 2019 Oct 15:405:116416. doi: 10.1016/j.jns.2019.08.001. Epub 2019 Aug 2.

Authors

Richard Shek-Kwan Chang¹, Hoi Ki Kate Lui², Yu Hin Ian Leung³, William C Y Leung³, Ka Keung Yam³, Yujie Wang³

Affiliations

¹ Division of Neurology, Department of Medicine, Queen Mary Hospital, University of Hong Kong, Hong Kong SAR, China. Electronic address: changsk@ha.org.hk.
² Division of Neurology, Department of Medicine, Tseung Kwan O Hospital, Hong Kong SAR, China.
³ Division of Neurology, Department of Medicine, Queen Mary Hospital, University of Hong Kong, Hong Kong SAR, China.

PMID: 31445298
DOI: 10.1016/j.jns.2019.08.001

No abstract available

Keywords: Anti-epileptic drug; Epilepsy; Perampanel; Seizure.

Publication types

Letter

MeSH terms

Adolescent
Adult
Aged
Anticonvulsants / adverse effects
Anticonvulsants / therapeutic use*
Child
Drug Combinations
Drug Resistant Epilepsy / drug therapy*
Female
Humans
Male
Middle Aged
Nitriles
Pyridones / adverse effects
Pyridones / therapeutic use*
Retrospective Studies
Treatment Outcome
Young Adult

Substances

Anticonvulsants
Drug Combinations
Nitriles
Pyridones
perampanel